Drug
Octa C1 Inh
Octa C1 Inh: highest development phase Phase 3, developed by Octapharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Octapharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| OCTA-C1-INH NCT06361537 | Phase 3 | Acute Hereditary Angio Edema |
Latest
No recent events.
Follow Octa C1 Inh on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.